Get in on Kiromic BioPharma Inc.’s (KRBP) buy-in window today!

Kiromic BioPharma Inc. (NASDAQ: KRBP) stock jumped 33.56% on Monday to $0.28 against a previous-day closing price of $0.21. With 3.71 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.11 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.2800 whereas the lowest price it dropped to was $0.2039. The 52-week range on KRBP shows that it touched its highest point at $1.26 and its lowest point at $0.15 during that stretch.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of KRBP was up-trending over the past week, with a rise of 31.78%, but this was up by 45.79% over a month. Three-month performance dropped to -17.02% while six-month performance fell -22.19%. The stock lost -78.02% in the past year, while it has gained 53.29% so far this year. A look at the trailing 12-month EPS for KRBP yields -2.46 with Next year EPS estimates of -1.55. For the next quarter, that number is -0.75. This implies an EPS growth rate of 16.70% for this year and 33.50% for next year.

Float and Shares Shorts:

At present, 15.84 million KRBP shares are outstanding with a float of 15.52 million shares on hand for trading. On Oct 13, 2022, short shares totaled 0.6 million, which was 3.81% higher than short shares on Sep 14, 2022. In addition to Mr. Pietro Bersani CPA, J.D. as the firm’s CEO & Director, Dr. Scott Dahlbeck M.D., Pharm.D., PharmD serves as its Chief of Staff.


Institutional Ownership:

Through their ownership of 6.81% of KRBP’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 17.45% of KRBP, in contrast to 10.82% held by mutual funds. Shares owned by individuals account for 0.22%. As the largest shareholder in KRBP with 9.99% of the stake, Sabby Management LLC holds 1,822,847 shares worth 1,822,847. A second-largest stockholder of KRBP, Yorkville Advisors Global LP, holds 603,318 shares, controlling over 3.31% of the firm’s shares. Empery Asset Management LP is the third largest shareholder in KRBP, holding 491,554 shares or 2.69% stake. With a 0.20% stake in KRBP, the Fidelity Nasdaq Composite Index F is the largest stakeholder. A total of 36,662 shares are owned by the mutual fund manager. The Fidelity Extended Market Index Fu, which owns about 0.02% of KRBP stock, is the second-largest Mutual Fund holder. It holds 4,285 shares valued at 776.0. USAA Extended Market Index Fund holds 0.00% of the stake in KRBP, owning 0 shares worth 0.0.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for KRBP since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.


EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. KRBP will report FY 2022 earnings on 02/28/2024. Analysts have provided yearly estimates in a range of -$2.33 being high and -$2.33 being low. For KRBP, this leads to a yearly average estimate of -$2.33. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Kiromic BioPharma Inc. surprised analysts by -$0.19 when it reported -$0.75 EPS against a consensus estimate of -$0.56. The surprise factor in the prior quarter was -$0.13. Based on analyst estimates, the high estimate for the next quarter is -$0.56 and the low estimate is -$0.56. The average estimate for the next quarter is thus -$0.56.

Summary of Insider Activity:

Insiders traded KRBP stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 4 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 755,538 while 0 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *